492 related articles for article (PubMed ID: 26618219)
1. Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizons.
Thabit H; Hovorka R
Expert Opin Drug Deliv; 2016; 13(3):389-400. PubMed ID: 26618219
[TBL] [Abstract][Full Text] [Related]
2. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
[TBL] [Abstract][Full Text] [Related]
3. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E;
Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468
[TBL] [Abstract][Full Text] [Related]
4. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
5. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.
Cummins E; Royle P; Snaith A; Greene A; Robertson L; McIntyre L; Waugh N
Health Technol Assess; 2010 Feb; 14(11):iii-iv, xi-xvi, 1-181. PubMed ID: 20223123
[TBL] [Abstract][Full Text] [Related]
6. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
[TBL] [Abstract][Full Text] [Related]
7. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.
Golden SH; Sapir T
J Manag Care Pharm; 2012 Aug; 18(6 Suppl):S1-17. PubMed ID: 22984955
[TBL] [Abstract][Full Text] [Related]
8. Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK.
Roze S; Valentine WJ; Zakrzewska KE; Palmer AJ
Diabet Med; 2005 Sep; 22(9):1239-45. PubMed ID: 16108855
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
[TBL] [Abstract][Full Text] [Related]
10. Optimizing type 1 diabetes after multiple daily injections and capillary blood monitoring: Pump or sensor first? A meta-analysis using pooled differences in outcome measures.
Thomas MG; Avari P; Godsland IF; Lett AM; Reddy M; Oliver N
Diabetes Obes Metab; 2021 Nov; 23(11):2521-2528. PubMed ID: 34286892
[TBL] [Abstract][Full Text] [Related]
11. Impact of technology on glycaemic control in type 2 diabetes: A meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion.
Dicembrini I; Mannucci E; Monami M; Pala L
Diabetes Obes Metab; 2019 Dec; 21(12):2619-2625. PubMed ID: 31368658
[TBL] [Abstract][Full Text] [Related]
12. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
Pickup JC; Sutton AJ
Diabet Med; 2008 Jul; 25(7):765-74. PubMed ID: 18644063
[TBL] [Abstract][Full Text] [Related]
13. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis.
Jeitler K; Horvath K; Berghold A; Gratzer TW; Neeser K; Pieber TR; Siebenhofer A
Diabetologia; 2008 Jun; 51(6):941-51. PubMed ID: 18351320
[TBL] [Abstract][Full Text] [Related]
14. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.
Colquitt JL; Green C; Sidhu MK; Hartwell D; Waugh N
Health Technol Assess; 2004 Oct; 8(43):iii, 1-171. PubMed ID: 15488165
[TBL] [Abstract][Full Text] [Related]
15. Continuous subcutaneous insulin infusion versus multiple daily injections for type 1 diabetes.
Ross LJ; Neville KA
J Paediatr Child Health; 2019 Jun; 55(6):718-722. PubMed ID: 31155794
[TBL] [Abstract][Full Text] [Related]
16. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
Sulli N; Shashaj B
Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
[TBL] [Abstract][Full Text] [Related]
17. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
[TBL] [Abstract][Full Text] [Related]
18. Glyco-metabolic control, inflammation markers, and cardiovascular outcomes in type 1 and type 2 diabetic patients on insulin pump or multiple daily injection (italico study).
Derosa G; Catena G; Scelsi L; D'Angelo A; Raddino R; Cosentino E; Maggi A; Pasini G; Borghi C; Maffioli P
Diabetes Metab Res Rev; 2020 Jan; 36(1):e3219. PubMed ID: 31642581
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Effectiveness of Continuous Subcutaneous Insulin Infusion in the Prevention of Hypoglycemia in Adults with Type 1 Diabetes.
Summers JC; Briganti EM; Fitzgerald ZA; Lambers LNJ; Cohen ND
Diabetes Technol Ther; 2019 Aug; 21(8):423-429. PubMed ID: 31180239
[No Abstract] [Full Text] [Related]
20. Continuous subcutaneous insulin infusion therapy: effects on quality of life.
Scheidegger U; Allemann S; Scheidegger K; Diem P
Swiss Med Wkly; 2007 Aug; 137(33-34):476-82. PubMed ID: 17990132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]